Geode Capital Management
SIOX

Geode Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-432,270
Closed -$188K 4861
2022
Q4
$188K Sell
432,270
-1,116
-0.3% -$485 ﹤0.01% 4136
2022
Q3
$121K Hold
433,386
﹤0.01% 4484
2022
Q2
$156K Buy
433,386
+2,178
+0.5% +$784 ﹤0.01% 4400
2022
Q1
$288K Hold
431,208
﹤0.01% 4198
2021
Q4
$556K Buy
431,208
+37,404
+9% +$48.2K ﹤0.01% 3990
2021
Q3
$854K Sell
393,804
-14,283
-3% -$31K ﹤0.01% 3765
2021
Q2
$1.11M Buy
408,087
+360,218
+753% +$983K ﹤0.01% 3535
2021
Q1
$124K Hold
47,869
﹤0.01% 4255
2020
Q4
$133K Buy
47,869
+24,811
+108% +$68.9K ﹤0.01% 4005
2020
Q3
$106K Sell
23,058
-35,255
-60% -$162K ﹤0.01% 3889
2020
Q2
$164K Buy
58,313
+14,088
+32% +$39.6K ﹤0.01% 3713
2020
Q1
$107K Buy
44,225
+8,378
+23% +$20.3K ﹤0.01% 3744
2019
Q4
$183K Buy
35,847
+15,732
+78% +$80.3K ﹤0.01% 3825
2019
Q3
$129K Hold
20,115
﹤0.01% 3891
2019
Q2
$125K Sell
20,115
-155,636
-89% -$967K ﹤0.01% 3908
2019
Q1
$233K Buy
175,751
+80,664
+85% +$107K ﹤0.01% 3694
2018
Q4
$94K Buy
95,087
+51,499
+118% +$50.9K ﹤0.01% 3873
2018
Q3
$105K Sell
43,588
-127,282
-74% -$307K ﹤0.01% 3914
2018
Q2
$386K Buy
170,870
+60,016
+54% +$136K ﹤0.01% 3523
2018
Q1
$147K Buy
110,854
+7,234
+7% +$9.59K ﹤0.01% 3765
2017
Q4
$546K Sell
103,620
-52,613
-34% -$277K ﹤0.01% 3325
2017
Q3
$1.07M Buy
156,233
+101,973
+188% +$701K ﹤0.01% 3092
2017
Q2
$1.26M Buy
54,260
+12,962
+31% +$301K ﹤0.01% 2998
2017
Q1
$616K Buy
41,298
+6,308
+18% +$94.1K ﹤0.01% 3230
2016
Q4
$434K Buy
34,990
+4,128
+13% +$51.2K ﹤0.01% 3318
2016
Q3
$432K Buy
30,862
+2,331
+8% +$32.6K ﹤0.01% 3310
2016
Q2
$366K Buy
28,531
+13,734
+93% +$176K ﹤0.01% 3350
2016
Q1
$169 Sell
14,797
-2,425
-14% -$28 ﹤0.01% 3685
2015
Q4
$310K Buy
17,222
+3,766
+28% +$67.8K ﹤0.01% 3496
2015
Q3
$173K Buy
+13,456
New +$173K ﹤0.01% 3731